Ignite Creation Date:
2024-05-06 @ 3:32 PM
Last Modification Date:
2024-10-26 @ 1:51 PM
Study NCT ID:
NCT04669600
Status:
COMPLETED
Last Update Posted:
2024-02-22
First Post:
2020-12-09
Brief Title:
A Phase 2a Study Evaluating BIVV020 in Adults With PersistentChronic Immune Thrombocytopenia ITP
Sponsor:
Bioverativ a Sanofi company
Organization:
Sanofi
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-02-04
Start Date Type:
ACTUAL
Primary Completion Date:
2022-02-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-02-07
Completion Date Type:
ACTUAL
First Submit Date:
2020-12-09
First Submit QC Date:
December 9 2020
Study First Post Date:
2020-12-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2024-02-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2023-02-13
Disp First Submit QC Date:
February 20 2024
Disp First Post Date:
2024-02-22
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-02-20
Last Update Post Date:
2024-02-22
Last Update Post Date Type:
ACTUAL